PMCB PharmaCyte Biotech
- 1.801
- -0.009-0.50%
- 1.890
- +0.089+4.95%
PharmaCyte Biotech News
PharmaCyte Biotech | 10-Q: Q1 2025 Earnings Report
PharmaCyte Biotech | 10-K: FY2024 Annual Report
PharmaCyte Biotech Announces $7 Million Strategic Investment in MYMD
PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.
Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
PharmaCyte Completes Tender Offer to Purchase Shares
PharmaCyte Biotech Announces Final Results of Tender Offer
Pancreatic Cancer Action Network Urges Advocates From All 50 States To Call On Congress To Increase Federal Funding For Pancreatic Cancer Research
PharmaCyte Biotech Shares Up 13% to 52-Week High After Cash Tender Offer
Organogenesis, Arcturus Top Healthcare Gainers; ImmunityBio, Dynatronics Among Losers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
PharmaCyte Biotech Completes $35M Private Placement >PMCB
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
Omega Therapeutics (NASDAQ:OMGA) & PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Contrast
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 0.7%
PharmaCyte Biotech (OTCMKTS:PMCB) and Ocugen (NASDAQ:OCGN) Critical Review
Cortexyme (NASDAQ:CRTX) Versus PharmaCyte Biotech (OTCMKTS:PMCB) Critical Survey
Cortexyme (NASDAQ:CRTX) and PharmaCyte Biotech (OTCMKTS:PMCB) Financial Comparison
Analysis
Price Target
No Data
No Data